TRIPLE EIGHT PROTEINS LIMITED

TRIPLE EIGHT PROTEINS LIMITED

TRIPLE EIGHT PROTEINS LIMITED - Company Information

Print Friendly Version

TRIPLE EIGHT PROTEINS LIMITED

Company Registration Number:
NI601701 (Northern Ireland)

Unaudited statutory accounts for the year ended 30 June 2022

Period of accounts

Start date: 1 July 2021

End date: 30 June 2022

TRIPLE EIGHT PROTEINS LIMITED

Contents of the Financial Statements

for the Period Ended 30 June 2022

Profit and loss
Balance sheet
Additional notes
Balance sheet notes

TRIPLE EIGHT PROTEINS LIMITED

Profit And Loss Account

for the Period Ended 30 June 2022

2022 2021


£
£
Turnover: 0 0
Cost of sales: 0 0
Gross profit(or loss): 0 0
Distribution costs: 0 0
Administrative expenses: ( 65 ) ( 55 )
Other operating income: 0 0
Operating profit(or loss): (65) (55)
Interest receivable and similar income: 0 0
Interest payable and similar charges: 0 0
Profit(or loss) before tax: (65) (55)
Tax: 0 0
Profit(or loss) for the financial year: (65) (55)

TRIPLE EIGHT PROTEINS LIMITED

Balance sheet

As at 30 June 2022

Notes 2022 2021


£
£
Called up share capital not paid: 0 0
Fixed assets
Intangible assets:   0 0
Tangible assets:   0 0
Investments:   0 0
Total fixed assets: 0 0
Current assets
Stocks:   0 0
Debtors:   0 0
Cash at bank and in hand: 9,697 9,762
Investments:   0 0
Total current assets: 9,697 9,762
Prepayments and accrued income: 0 0
Creditors: amounts falling due within one year:   0 0
Net current assets (liabilities): 9,697 9,762
Total assets less current liabilities: 9,697 9,762
Creditors: amounts falling due after more than one year:   0 0
Provision for liabilities: 0 0
Accruals and deferred income: 0 0
Total net assets (liabilities): 9,697 9,762
Capital and reserves
Called up share capital: 1 1
Share premium account: 0 0
Other reserves: 0 0
Profit and loss account: 9,696 9,761
Total Shareholders' funds: 9,697 9,762

The notes form part of these financial statements

TRIPLE EIGHT PROTEINS LIMITED

Balance sheet statements

For the year ending 30 June 2022 the company was entitled to exemption under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

This report was approved by the board of directors on 11 October 2022
and signed on behalf of the board by:

Name: Edward Gleeson
Status: Director

The notes form part of these financial statements

TRIPLE EIGHT PROTEINS LIMITED

Notes to the Financial Statements

for the Period Ended 30 June 2022

  • 1. Accounting policies

    Basis of measurement and preparation

    These financial statements have been prepared in accordance with the provisions of Section 1A (Small Entities) of Financial Reporting Standard 102

    Other accounting policies

    Statement of compliance, Basis of preparation, Related parties, Taxation and deferred taxation, Foreign currencies, Ordinary Share Capital

TRIPLE EIGHT PROTEINS LIMITED

Notes to the Financial Statements

for the Period Ended 30 June 2022

  • 2. Employees

    2022 2021
    Average number of employees during the period 0 0

TRIPLE EIGHT PROTEINS LIMITED

Notes to the Financial Statements

for the Period Ended 30 June 2022

3. Financial Commitments

The company had no material capital commitments at the financial period-ended 30 June 2022

TRIPLE EIGHT PROTEINS LIMITED

Notes to the Financial Statements

for the Period Ended 30 June 2022

4. Off balance sheet arrangements

There have been no significant events affecting the company since the financial period-end